Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Effects of Ketamine on ERP/EEG Measures in Healthy Volunteers
ERP Biomarker Qualification Consortium
Opioid-free Vs Traditional Balanced Anesthesia in Laparoscopic Colorectal Surgery
Unai Ortega Mera
Effects of Stimulants on Behavioral and Neural Markers of Social Motivation, Ability, and Neural Markers of Social Function
University of Chicago
Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
University of Texas Southwestern Medical Center
Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression
Centre for Addiction and Mental Health
Effects of LSD on Neuroplasticity in Healthy Subjects
University of Fribourg
Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial
Washington University School of Medicine
Social Anxiety MDMA-Assisted Therapy Investigation
Jason B Luoma
Tolerance and Potential Synergistic Effect of the Combination of Intranasal Esketamine and Non-selective MAOI
University Hospital, Strasbourg, France
Randomized Trial of Sedative Choice for Intubation
Vanderbilt University Medical Center
Opioid-free Anesthesia and Thoracoscopy Surgery
Nantes University Hospital
Chart Review of Patients Undergoing Ketamine Treatments for Depression
Sunnybrook Health Sciences Centre
Effect of Ketamine on BIS Values
University of Padova
The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
Sheppard Pratt Health System
LSD Base and LSD Tartrate Bioequivalence and Bioavailability in Healthy Subjects
University Hospital, Basel, Switzerland
Evaluation of Psilocybin (TRP-8802) in the Treatment of Binge Eating Disorder
TRYP Therapeutics
Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care
Yvan Beaussant, MD, MSci
Frontline Clinician Psilocybin Study
University of Washington
Venous Cannulation Pain to Guide Choice of Anesthetic Method
Region Halland
Single Ascending Dose Study With BPL-003 in Healthy Subjects
Beckley Psytech Limited
A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD
Perception Neuroscience
Ketamine + Mindfulness for Depression
Rebecca Price
Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest
University of Milano Bicocca
Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial
Definium Therapeutics US, Inc.
Effects of MDMA-like Substances in Healthy Subjects
University Hospital, Basel, Switzerland
Ketamine for the Treatment of Depression in Parkinson's Disease
Yale University
Psilocybin for Treatment-Resistant Depression
Brain and Cognition Discovery Foundation
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy
Celgene
Effectiveness of Ketamine Administered by Mesotherapy in Complex Regional Pain Syndrome Type 1 (CRPS1)
Hospices Civils de Lyon
Stanford Regulating Circuits of the Brain Study - MDMA
Stanford University
Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
Centre for Addiction and Mental Health
Synaptic Imaging and Network Activity in Treatment Resistant Depression
King's College London
Identification of a Safe and Non-Psychedelic Dose of Psilocybin
Diamond Therapeutics Inc.
Characteristics and Treatment Patterns of Patients With Sickle Cell Disease in Globin Research Network for Data and Discovery Registry
Novartis
Benefits of Opioid Free Anesthesia on Morphine Consumption in Gastric Bypass
matthieu clanet
A Phase 2 Open-Label Treatment Development Study of MDMA-Assisted Cognitive Processing Therapy (CPT) for Posttraumatic Stress Disorder (PTSD)
Remedy
Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
University of Utah
Comparison of Nebulized Ketamine to Intravenous Sub-Dissociative Dose Ketamine for Pain
Antonios Likourezos
Low Dose Ketamine for Blunt Thoracic Trauma
North Memorial Health Care
Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
King's College London
Single Ascending Dose Study With 5-MeO-DMT in Healthy Subjects
Beckley Psytech Limited
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
Supernus Pharmaceuticals, Inc.
Repeated Neurocognitive Measurements in Depressed Patients
Rebecca Price
Entheogen Resurgence
Vireo Health
Ketamine + Magnesium for Chronic Cluster Headache (KETALGIA)
University Hospital, Clermont-Ferrand
Ketamine As an Adjunctive Therapy for Major Depression (2)
University of Dublin, Trinity College
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
University Hospital, Basel, Switzerland
Pharmacokinetic Study of Intranasal CT001 in Children 1-17 Years of Age Undergoing Elective Surgical Procedures
Cessatech A/S
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.